NCT07011043 - A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

Budoprutug

Single IV dose of study product on Day 1 of study

Trial Locations (8)

RECRUITING

Climb Bio Investigative Site #100101, San Antonio

RECRUITING

Climb Bio Investigative Site #100103, Caguas

RECRUITING

Climb Bio Investigative Site #380102, Ivano-Frankivsk

RECRUITING

Climb Bio Investigative Site #380103, Kyiv

RECRUITING

Climb Bio Investigative Site #380106, Kyiv

RECRUITING

Climb Bio Investigative Site #380101, Ternopil

RECRUITING

Climb Bio Investigative Site #380104, Vinnytsia

RECRUITING

Climb Bio Investigative Site #380105, Vinnytsia